Structural Rearrangements of the 10–23 DNAzyme to β3 Integrin Subunit mRNA Induced by Cations and Their Relations to the Catalytic Activity*

The intracellular ability of the “10–23” DNAzyme to efficiently inhibit expression of targeted proteins has been evidenced by in vitro and in vivo studies. However, standard conditions for kinetic measurements of the DNAzyme catalytic activity in vitro include 25 mm Mg2+, a concentration that is very unlikely to be achieved intracellularly. To study this discrepancy, we analyzed the folding transitions of the 10–23 DNAzyme induced by Mg2+. For this purpose, spectroscopic analyzes such as fluorescence resonance energy transfer, fluorescence anisotropy, circular dichroism, and surface plasmon resonance measurements were performed. The global geometry of the DNAzyme in the absence of added Mg2+ seems to be essentially extended, has no catalytic activity, and shows a very low binding affinity to its RNA substrate. The folding of the DNAzyme induced by binding of Mg2+ may occur in several distinct stages. The first stage, observed at 0.5 mm Mg2+, corresponds to the formation of a compact structure with limited binding properties and without catalytic activity. Then, at 5 mm Mg2+, flanking arms are projected at right position and angles to bind RNA. In such a state, DNAzyme shows substantial binding to its substrate and significant catalytic activity. Finally, the transition occurring at 15 mm Mg2+ leads to the formation of the catalytic domain, and DNAzyme shows high binding affinity toward substrate and efficient catalytic activity. Under conditions simulating intracellular conditions, the DNAzyme was only partially folded, did not bind to its substrate, and showed only residual catalytic activity, suggesting that it may be inactive in the transfected cells and behave like antisense oligodeoxynucleotide.

[1]  G. F. Joyce,et al.  Mechanism and utility of an RNA-cleaving DNA enzyme. , 1998, Biochemistry.

[2]  G D Stormo,et al.  Sequence requirements of the hammerhead RNA self-cleavage reaction. , 1990, Biochemistry.

[3]  G. F. Joyce,et al.  A general purpose RNA-cleaving DNA enzyme. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[4]  D. Rhodes,et al.  The DNA binding site of the Xenopus transcription factor IIIA has a non‐B‐form structure. , 1989, The EMBO journal.

[5]  P. Tien,et al.  Suppression of platelet-type 12-lipoxygenase activity in human erythroleukemia cells by an RNA-cleaving DNAzyme. , 2001, Biochemical and biophysical research communications.

[6]  Y. Lyubchenko,et al.  Atomic force microscopy study of the effects of Mg(2+) and other divalent cations on the end-to-end DNA interactions. , 2002, Biochemistry.

[7]  D. Gray,et al.  CD, absorption and thermodynamic analysis of repeating dinucleotide DNA, RNA and hybrid duplexes [d/r(AC)]12.[d/r(GT/U)]12 and the influence of phosphorothioate substitution. , 1997, Nucleic acids research.

[8]  D. Lilley,et al.  Ion‐induced folding of the hammerhead ribozyme: a fluorescence resonance energy transfer study , 1997, The EMBO journal.

[9]  D. Lilley,et al.  Observing the helical geometry of double-stranded DNA in solution by fluorescence resonance energy transfer. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Flaherty,et al.  Model for an RNA tertiary interaction from the structure of an intermolecular complex between a GAAA tetraloop and an RNA helix , 1994, Nature.

[11]  V. Potaman,et al.  Triple-Helical Nucleic Acids , 1995, Springer New York.

[12]  S. Stass,et al.  Angiogenic inhibition mediated by a DNAzyme that targets vascular endothelial growth factor receptor 2. , 2002, Cancer research.

[13]  B. Stoddard,et al.  Capturing the Structure of a Catalytic RNA Intermediate: The Hammerhead Ribozyme , 1996, Science.

[14]  D. Mckay,et al.  Structure and function of the hammerhead ribozyme: an unfinished story. , 1996, RNA.

[15]  J. Lakowicz Principles of fluorescence spectroscopy , 1983 .

[16]  R. Clegg Fluorescence resonance energy transfer and nucleic acids. , 1992, Methods in enzymology.

[17]  A. Klug,et al.  The crystal structure of an AII-RNAhammerhead ribozyme: A proposed mechanism for RNA catalytic cleavage , 1995, Cell.

[18]  W. Stec,et al.  DNAzymes to β1 and β3 mRNA Down-regulate Expression of the Targeted Integrins and Inhibit Endothelial Cell Capillary Tube Formation in Fibrin and Matrigel* , 2002, The Journal of Biological Chemistry.

[19]  K. Taira,et al.  Effects of helical structures formed by the binding arms of DNAzymes and their substrates on catalytic activity. , 1998, Nucleic acids research.

[20]  W. Stec,et al.  Inhibition by modified oligodeoxynucleotides of the expression of type-1 plasminogen activator inhibitor in human endothelial cells. , 1995, European journal of biochemistry.

[21]  Yang Li,et al.  Cellular uptake, distribution, and stability of 10-23 deoxyribozymes. , 2002, Antisense & nucleic acid drug development.

[22]  M. Komiyama,et al.  Evidence for the rate-limiting departure of the 5'-oxygen in nonenzymatic and hammerhead ribozyme-catalyzed reactions , 1996 .

[23]  T. Wagner,et al.  Double‐helical DNA and RNA circular dichroism. Calculations on base–sugar‐phosphate helix interactions , 1974, Biopolymers.

[24]  E. Jaffe,et al.  Synthesis of basement membrane collagen by cultured human endothelial cells , 1976, The Journal of experimental medicine.

[25]  K. Flaherty,et al.  Three-dimensional structure of a hammerhead ribozyme , 1994, Nature.

[26]  G. Magnusson,et al.  Lactose repressor-operator DNA interactions: kinetic analysis by a surface plasmon resonance biosensor. , 1993, Analytical biochemistry.

[27]  J B Welch,et al.  Structures of bulged three-way DNA junctions. , 1993, Nucleic acids research.

[28]  K. Taira,et al.  Comparison of metal-ion-dependent cleavages of RNA by a DNA enzyme and a hammerhead ribozyme. , 2002, Biomacromolecules.

[29]  Andreas D. Baxevanis,et al.  The Molecular Biology Database Collection: 2003 update , 2003, Nucleic Acids Res..

[30]  E. Jaffe,et al.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. , 1973, The Journal of clinical investigation.

[31]  K. Taira,et al.  Mechanistic Studies on Hammerhead Ribozymes , 1996 .

[32]  O. Uhlenbeck,et al.  Role of divalent metal ions in the hammerhead RNA cleavage reaction. , 1991, Biochemistry.

[33]  Levon M Khachigian DNAzymes: cutting a path to a new class of therapeutics. , 2002, Current opinion in molecular therapeutics.